Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
152M
-
Number of holders
-
187
-
Total 13F shares, excl. options
-
140M
-
Shares change
-
+3.34M
-
Total reported value, excl. options
-
$766M
-
Value change
-
+$15.4M
-
Put/Call ratio
-
0.86
-
Number of buys
-
70
-
Number of sells
-
-108
-
Price
-
$5.45
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q3 2023
226 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q3 2023.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 140M shares
of 152M outstanding shares and own 92.51% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (30M shares), VANGUARD GROUP INC (12.2M shares), BlackRock Inc. (11.6M shares), Matrix Capital Management Company, LP (11.6M shares), ARK Investment Management LLC (11.5M shares), Sumitomo Mitsui Trust Holdings, Inc. (6.57M shares), Nikko Asset Management Americas, Inc. (6.57M shares), Point72 Asset Management, L.P. (5.71M shares), Aristotle Atlantic Partners, LLC (3.06M shares), and Pictet Asset Management Holding SA (3.04M shares).
This table shows the top 187 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.